NextCure Inc. (NXTC) Prices 4.077M Share Common Offering at $36.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
NextCure Announces Pricing of Public Offering of Common Stock
November 14, 2019 10:11 PM ESTBELTSVILLE, Md., Nov. 14, 2019 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the pricing of its public offering of 4,077,192 shares of its common stock at a public offering price of $36.75 per share. NextCure also granted the underwriters a 30-day option to purchase up to an additional 611,578 shares of its common stock at the public offering price less the underwriting discounts and commissions. All of the common stock to... More
NextCure Announces Pricing of Public Offering of Common Stock
November 14, 2019 10:09 PM ESTBELTSVILLE, Md., Nov. 14, 2019 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the pricing of its public offering of 4,077,192 shares of its common stock at a public offering price of $36.75 per share. NextCure also granted the underwriters a 30-day option to purchase up to an additional 611,578 shares of its common stock at the public offering price less the underwriting discounts and commissions. All of the common stock to be sold in the offering are being... More



